average weight loss with glp-1 agonists The Multi-Sector Impacts of GLP-1RA Drugs GLP-1 Agonists Weight Loss Drugs
Description
Gewitz, A
For instance, How Type 2 Diabetes (T2D) Segment Dominated the GLP-1 Drugs Market in 2025
In addition to safeguarding the cardiovascular system, GLP-1RA also exerts a protective effect on the kidney
Secondary endpoints Weight loss A difference in weight loss was already seen at M3 (9.2% [3.6] vs
Rosenbaum notes
And in August, Pfizer ended development of its third and final oral GLP-1 candidate, PF-06954522, after a review of its phase 1 clinical performance and the overall GLP-1 landscape
